Evgeny O. Rodionov
Contact details
e-mail: rodionov_eo@oncology.tomsk.ru
Education
2007-2012: student of Siberian State Medical University
2012 – 2015: clinical resident in oncology at Cancer Research Institute
2015-2018: graduate student at Cancer Research Institute
2018: Ph.D. thesis titled “Combined modality treatment including preoperative chemotherapy and personalized adjuvant chemotherapy for stage III non-small cell lung cancer”
Academic position
2018 –present: assistant, Oncology Department, Siberian State Medical University
2019-present: Senior Researcher, Thoracic Cancer Department, Cancer Research Institute, Tomsk NRMC
Major research interests: development of personalized approaches to the treatment and rehabilitation of patients with lung cancer considering clinical, morphological and molecular genetic characteristics of the tumor.
Achievements, awards, grants
- Author of 30 scientific publications, 4 patents for inventions of the Russian Federation.
- Laureate of the Russian Government Scholarship to graduate students for 2017-2018.
- Prizewinner and winner of competitions of young scientists (2015, Tomsk); All-Russian conference of young oncologists dedicated to the memory of Prof. N .V. Vasilieva (2016, Tomsk); All-Russian competition of young scientists in oncology as part of the XX Russian Oncology Congress (2016, Moscow); Competition of scientific works of young scientists of Russia (2017, St. Petersburg).
Main publications
1. Tsyganov M.M., Deryusheva I.V., Rodionov E.O., Efteev L.A., Miller S.V., Ibragimova M.K., Perminova E.E., Cheremisina O.V., Frolova I.G., Tuzikov S.A., Litvyakov N.V. Chemosensitivity gene mRNA expression as a predictor of response to neoadjuvant chemotherapy for non-small cell lung cancer. Siberian Oncology Journal. 2019 18 (1): 13–20. - doi: 10.21294 / 1814-4861-2019-18-1-13-20.
2. Tsyganov M.M., Deryusheva I.V., Rodionov E.O., Ibragimova M.K., Miller S.V., Litvyakov N.V. Monoresistance genes as a marker for the personalization of chemotherapy for lung cancer // Molecular Medicine. - 2018.- V.16, No. 1.- 3-9.
3. Rodionov E.O., Miller S.V., Tuzikov S.A., Kravchuk T.L., Bondar L.N., Urmonov U.B., Savenkova O.V. Hodgkin lymphoma with primary lung lesion: a rare clinical case // Bulletin of Avicenna. 2018; 20 (4): 479-482. DOI: 10.25005 / 2074-0581-2018-20-4-479-482
4. Tsyganov M.M., Rodionov E.O., Deryusheva I.V., Miller S.V., Ibragimova M.K., Pisareva L.F., Kzhyshkovskaya Yu.G., Tuzikov S.A., Cherdyntseva N.V., Litvyakov N.V. Evaluation of the prognostic significance of monoresistance gene expression in tumors of patients with non-small cell lung cancer after preoperative chemotherapy // Oncology Issues. 2017.Vol. 63. No. 1. P. 122-127.
5. 5. Rodionov E.O., Miller S.V., Tsyganov M.M., Cheremisina O.V., Tuzikov S.A., Litvyakov N.V., Frolova I.G., Velichko S.A., Lukyanenok P.I., Polishchuk T.V. A personalized approach to postoperative chemotherapy in the combined treatment of non-small cell lung cancer (clinical observation) // Siberian Oncology Journal. 2016. Volume 15, No. 3 - S. 97-101. DOI: 10.21294 / 1814-4861-2016-15-3-97-101.
6. Tsyganov M.M., Rodionov E.O., Miller S.V., Litvyakov N.V. The rationale for the use of expression markers to personalize chemotherapy for lung cancer // Antibiotics and chemotherapy. - 2015.- No. 9-10.- P.34-42.
7. 7. Miller S.V., Volkov M.Yu., Rodionov E.O., Tuzikov S.A., Evtushenko V.V., Lukyanenok P.I., Evtushenko A.V. The experience of angioplastic operations in non-small cell lung cancer // International Journal of Applied and Fundamental Research. - 2016. - No. 6-2. - P. 263-269.
8. Miller S.V., Balatskaya L.N., Tuzikov S.A., Goldberg V.E., Polishchuk T.V., Yumov E.L., Rodionov E.O. The quality of life of patients with the combined treatment of non-small cell lung cancer // Bulletin of the Federal State Budgetary Institution "Russian Research Center named after N.N. Blokhin ", v. 26. 2015. P. 23-28
9. 9. Yumov E.L., Miller S.V., Litvyakov N.V., Polishchuk T.V., Tuzikov S.A., Cheremisina O.V., Goldberg V.E., Rodionov E.O. Chemotherapy in the combined treatment of locally advanced non-small cell lung cancer // Siberian Journal of Oncology. 2014. No. 2 (62). P. 9-13.